The National Prostate Cancer Research Consortium (NPCRC) is a multi-disciplinary, trans-institutional collaboration bringing together researchers from UCD, TCD, UCC, RCSI, DCU, NUI-Galway, Cancer Trials Ireland and the National Cancer Registry in a combined effort to personalise treatment and care for men with prostate cancer to improve outcomes and optimise quality of life.

This network has built upon previous collaborative prostate cancer research initiatives, including the Prostate Cancer Research Consortium (PCRC) which has had three successful funding cycles from the Irish Cancer Society (with support from Movember) since 2006 and brought together clinicians and scientists to address clinically relevant unmet needs in the stratification of patients for appropriate treatment interventions for early stage disease. The NPCRC formed the anchor for two programmes of research which secured internationally peer-reviewed funding:

1. Irish Prostate Cancer Outcomes Research (IPCOR; www.ipcor.ie), which aims to effectively record and report on outcomes of prostate cancer treatments and care with a view to improving the lives of those living with and beyond prostate cancer
2. The Irish PROgramme for Stratified ProstatE Cancer Therapy (iPROSPECT) which aims to build capacity to personalise treatments of patients with metastatic disease in order to improve treatment outcomes.

Find out more on the NPCRC Research, Team or Publications at https://www.crdi.ie/national-prostate-cancer-research-consortium-npcrc/